XML 17 R6.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Statements of Equity - USD ($)
$ in Thousands
Total
Total Stockholders’ Equity
Common Stock
Additional Paid-in Capital
Treasury Stock
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Noncontrolling Interests in Subsidiaries
Common stock, outstanding, beginning balance (in shares) at Dec. 29, 2019     168,121,000          
Stockholders' equity, beginning of period at Dec. 29, 2019 $ 21,499 $ 10,163 $ 168 $ 2,661,819 $ (192,633) $ (9,512) $ (2,449,679) $ 11,336
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (2,138) (1,431)         (1,431) (707)
Other comprehensive income 723 723       723    
Issuance of restricted stock to employees, net of cancellations (in shares)     2,452,000          
Issuance of restricted stock to employees, net of cancellations 3 3 $ 3          
Stock-based compensation expense 6,885 6,885   6,885        
Purchases of treasury stock (in shares)     (818,000)          
Purchases of treasury stock (6,911) (6,911) $ (1)   (6,910)      
Common stock, outstanding, ending balance (in shares) at Mar. 29, 2020     169,755,000          
Stockholders' equity, end of period at Mar. 29, 2020 $ 20,061 9,432 $ 170 2,668,704 (199,543) (8,789) (2,451,110) 10,629
Common stock, outstanding, beginning balance (in shares) at Jan. 03, 2021 170,428,000   170,428,000          
Stockholders' equity, beginning of period at Jan. 03, 2021 $ 406,486 404,167 $ 170 2,685,920 (205,476) 8,799 (2,085,246) 2,319
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (49,498) (48,385)         (48,385) (1,113)
Other comprehensive income 98 98       98    
Issuance of restricted stock to employees, net of cancellations (in shares)     1,908,000          
Issuance of restricted stock to employees, net of cancellations 2 2 $ 2          
Stock-based compensation expense 5,437 5,437   5,437     0  
Bond/Debentures Conversion (in shares)     4,000          
Bond/debentures conversion 155 155   155        
Purchases of treasury stock (in shares)     (76,000)          
Purchases of treasury stock (2,120) (2,120)     (2,120)      
Other adjustments $ 303 303   (89)     392  
Common stock, outstanding, ending balance (in shares) at Apr. 04, 2021 172,264,000   172,264,000          
Stockholders' equity, end of period at Apr. 04, 2021 $ 360,863 $ 359,657 $ 172 $ 2,691,423 $ (207,596) $ 8,897 $ (2,133,239) $ 1,206